Who owns KINNATE BIOPHARMA INC?
- Ticker: KNTE
- CUSIP Number: 49705r105
Tip: Access positions for across all investors
Analyze quarterly positions in Kinnate Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kinnate Biopharma stock
Who bought or sold KINNATE BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Foresite Capital Management IV | 9.7M | $385M | 100% | Dec 2020 | ||
| OrbiMed Advisors | 3.8M | $153M | 100% | Dec 2020 | ||
| RA Capital Management | 3.6M | $143M | 100% | Dec 2020 | ||
| Vida Ventures Advisors | 2.7M | $109M | 100% | Dec 2020 | ||
| FMR | 2.5M | $94M | 100% | Dec 2020 | ||
| Viking Global Investors | 1.9M | $75M | 100% | Dec 2020 | ||
| VR Adviser | 1.5M | $59M | 100% | Dec 2020 | ||
| Citadel Advisors | 1.3M | $52M | 100% | Dec 2020 | ||
| Boxer Capital | 1.1M | $42M | 100% | Dec 2020 | ||
| Foresite Capital Management V | 875k | $35M | 100% | Dec 2020 | ||
| Vanguard Group | 852k | $33M | 100% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Kinnate Biopharma? |
||||||
| Henderson Group | 806k | $30M | 100% | Dec 2020 | ||
| T. Rowe Price Associates | 649k | $26M | 100% | Dec 2020 | ||
| Logos Global Management | 570k | $23M | 100% | Dec 2020 | ||
| Harvard Management Company | 498k | $20M | 100% | Dec 2020 | ||
| Deerfield Management Company | 345k | $14M | 100% | Dec 2020 | ||
| Partner Fund Management | 342k | $14M | 100% | Dec 2020 | ||
| Rock Springs Capital Management | 325k | $13M | 100% | Dec 2020 | ||
| BlackRock | 310k | $12M | 100% | Dec 2020 | ||
| Novo A/S | 300k | $12M | 100% | Dec 2020 | ||
| Woodline Partners | 277k | $11M | 100% | Dec 2020 | ||
| Farallon Capital Management | 250k | $9.9M | 100% | Dec 2020 | ||
| Federated Investors | 250k | $9.9M | 100% | Dec 2020 | ||
| Franklin Resources | 175k | $7.0M | 100% | Dec 2020 | ||
| Eventide Asset Management | 175k | $7.0M | 100% | Dec 2020 | ||
| Invesco | 167k | $6.7M | 100% | Dec 2020 | ||
| Artal Group | 125k | $5.0M | 100% | Dec 2020 | ||
| Victory Capital Management | 107k | $4.2M | 100% | Dec 2020 | ||
| Millennium Management | 90k | $3.6M | 100% | Dec 2020 | ||
| DAFNA Capital Management | 68k | $2.7M | 100% | Dec 2020 | ||
| Goldman Sachs Group | 60k | $2.4M | 100% | Dec 2020 | ||
| Tudor Investment Corporation | 40k | $1.6M | 100% | Dec 2020 | ||
| UBS Group | 40k | $1.6M | 100% | Dec 2020 | ||
| TD Asset Management | 38k | $1.5M | 100% | Dec 2020 | ||
| Geode Capital Management | 30k | $1.2M | 100% | Dec 2020 | ||
| Pinz Capital Management | 26k | $1.0M | 100% | Dec 2020 | ||
| Norges Bank Investment Management | 25k | $995k | 100% | Dec 2020 | ||
| EcoR1 Capital | 25k | $995k | 100% | Dec 2020 | ||
| ExodusPoint Capital Management | 21k | $835k | 100% | Dec 2020 | ||
| Citigroup | 15k | $607k | 100% | Dec 2020 | ||
| Ensign Peak Advisors | 15k | $597k | 100% | Dec 2020 | ||
| Tibra Equities Europe | 13k | $533k | 100% | Dec 2020 | ||
| SG Americas Securities | 13k | $533k | 100% | Dec 2020 | ||
| Mirabella Financial Services | 10k | $412k | 100% | Dec 2020 | ||
| American Century Companies | 7.1k | $284k | 100% | Dec 2020 | ||
| Qube Research & Technologies | 6.1k | $242k | 100% | Dec 2020 | ||
| Jane Street | 6.0k | $241k | 100% | Dec 2020 | ||
| Maven Securities | 6.0k | $237k | 100% | Dec 2020 | ||
| Wellington Management Company | 5.7k | $227k | 100% | Dec 2020 | ||
| Hrt Financial | 5.6k | $223k | 100% | Dec 2020 | ||
| S.A.C. Capital Advisors | 5.5k | $217k | 100% | Dec 2020 | ||
| Rockefeller Capital Management | 3.3k | $129k | 100% | Dec 2020 | ||
| Ikarian Capital | 2.0k | $79k | 100% | Dec 2020 | ||
| Royal Bank of Canada | 500.00 | $20k | 100% | Dec 2020 | ||
| Pathstone Family Office | 198.00 | $8.0k | 100% | Dec 2020 | ||